0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Editorials |

Autoimmunity and Its Treatment in Aplastic Anemia

Neal S. Young, MD
[+] Article and Author Information

National Heart, Lung, and Blood Institute, Bethesda, MD 20892 Requests for Reprints: Neal S. Young, MD, National Heart, Lung, and Blood Institute, Building 10, Room 7C103, 9000 Rockville Pike, Bethesda, MD 20892-1652.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1997;126(2):166-168. doi:10.7326/0003-4819-126-2-199701150-00014
Text Size: A A A

A century ago, long before much was understood about blood cell production, astute clinicians inferred from the fatty bone marrow of their patients who had died of aplastic anemia a fundamental failure of hematopoiesis [1]. This conclusion has been fully confirmed by modern laboratory testing, including flow cytometric measurements of primitive blood cells that bear the CD34 antigen and tissue culture assays for progenitor and stem cells [2]. Severe aplastic anemia, which is characterized by profound depression of neutrophil, platelet, and erythrocyte counts, could not be effectively treated until bone marrow transplantation was developed in the 1970s. An adequate inoculum of bone marrow cells from an immunologically well-matched sibling donor was shown to correct the suspected simple deficiency of stem cells. The reason why the blood-forming bone marrow cells disappeared in the first place was unknown, but direct toxicity was suggested by two models: 1) the transient aplasia that regularly occurs with large doses of radiation or cytotoxic drugs used to treat cancer and 2) the relation between aplastic anemia and exposure to certain chemicals and drugs (most notoriously benzene and chloramphenicol), established from case histories and epidemiologic studies.

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)